Clinical trial / 2001
A low microparticle diet significantly reduced CDAI scores and induced remission in patients with active Crohn's disease compared to a control diet.
In a double-blind pilot study, 20 patients with active corticosteroid-treated ileal or ileo-colonic Crohn's disease were randomized to receive either a low microparticle diet (n = 10) or a control diet (n = 10) for 4 months. One patient in each group was withdrawn. The low microparticle diet group showed a progressive decrease in CDAI from baseline (392 +/- 25) to month 4 (145 +/- 47; P = 0.002 vs control group), with seven patients achieving remission (CDAI <150). In contrast, the control group returned to baseline CDAI levels (302 +/- 28 on entry vs 295 +/- 25 at month 4) with zero patients in remission; corticosteroid reduction in the trial group did not reach statistical significance.
- Study type
- Double-blind, randomized pilot study
- Who was studied
- 20 patients with active corticosteroid-treated ileal or ileo-colonic Crohn's disease
- What was measured
- Crohn's disease activity index (CDAI) and corticosteroid requirements
THE PAPER
Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease.
Lomer MC, Harvey RS, Evans SM, Thompson RP, Powell JJ. Eur J Gastroenterol Hepatol, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.